SWTX-143

N/A

Report date: 2024/05/08 17:14:01
NME

Base Information

Drug NameSWTX-143
Drug Alias NameSWTX-143
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscriptional enhancer factor inhibitors
TargetsTranscriptional enhancer factor
Therapy Area/IndicationsMesothelioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSpringworks Therapeutics IncVIB-KU Leuven Center for Cancer BiologyNovAliX SAS
China Registration ClassN/A

Develop Information

Active CompaniesNovAliX SASVIB-KU Leuven Center for Cancer BiologySpringworks Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMesothelioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A